簡易檢索 / 詳目顯示

研究生: 林豊鈞
Lin, Li-Chun
論文名稱: 利用銅催化合成異吲哚基[1,2-b]喹唑-12(10H)-酮及其衍生物
Synthesis of Isoindolo[1,2-b]quinazolin-12(10H)-one Derivatives via copper catalyzed Tandem Cyclization
指導教授: 姚清發
Yao, Ching-Fa
學位類別: 碩士
Master
系所名稱: 化學系
Department of Chemistry
論文出版年: 2019
畢業學年度: 107
語文別: 中文
論文頁數: 37
中文關鍵詞: 銅催化異吲哚合環反應
英文關鍵詞: Copper Catalyzed, Isoindolo, Cyclization
DOI URL: http://doi.org/10.6345/NTNU201900481
論文種類: 學術論文
相關次數: 點閱:177下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報

本論文主要是研究利用銅試劑來催化合成異吲哚基[1,2-b]喹唑-12(10H)-酮(isoindolo[1,2-b]quinazolin-12(10H)-one)及其衍生物的反應。此反應所合成的產物乃是特別針對具有潛力的藥物Batracylin中的結構進行改良。有關Batracylin的性質,目前從細胞實驗以及動物的實驗結果已發現它可以抑制腫瘤細胞的生成。而其抑制方式是讓細胞的DNA受損而導致無法進一步的進行細胞分裂,最終造成細胞死亡。然而另一個副作用則為N-乙酰化(N-acetylation)的反應常會造成正常細胞的中毒,最終甚至導致老鼠死亡,因此,我們希望能將Batracylin的部份結構進行改良,希望能減少其生物毒性,最終能變成具潛力的藥物。

The contents of this thesis divided into two parts. The first part describes the introduction of isoindolo[1,2-b]quinazolin-12(10H)-one derivatives pharmacological importance, previous reported procedures for the synthesis of these derivatives. Along with these introduction of copper catalyzed tandem cyclizations included in this chapter. Next, aim of the thesis also described as in last part of this chapter.
The second chapter deals about the synthesis of isoindolo[1,2-b]quinazolin-12(10H)-one derivatives by copper catalyzed tandem cyclization from the reaction of 2-iodo(N-(2-bromobenzyl)benzamide substrates and copper cyanide. A wide variety of 2-iodo(N-(2-bromobenzyl)benzamide substrates were utilized for the construction of variety of isoindolo[1,2-b]quinazolin-12(10H)-one derivatives in moderate to excellent yields. Further using the procedure, we synthesized Batracylin drug. Batracylin can inhibit the formation of tumor cells.

目錄 中文摘要………………………………………………………….……….I 英文摘要………………………………………………………………….II 第壹章、 前言 1. 前言……………………………………………………………….1 1-1. Batracylin 衍生物的介紹………………………………….....1 第貳章、 異吲哚基[1,2-b]喹唑-12(10H)-酮之結果與討論 2.異吲哚基[1,2-b]喹唑-12(10H)-酮之結果與討論…………….…..3 2-1. 研究動機以及目的………………………………………....……3 2-2. 化合物 3 及其衍生物的合成…………………………………..5 2-3. 最佳化條件探討………………………………….…………….8 2-4. 化合物 4 取代基的探討……………………………………….10 2-5.反應機構探討……………………………………………………12 3. 結論…………………………………………………….……………13 實驗部份 1H-NMR 及 13C-NMR 光譜圖……………………………………...14 參考文獻………………………………………………….……….……37

1 V. Ashutosh Ra, Keli Agama, Susan Holbeck ; Cancer Res 2007;67:9971-9979.
2 Plowman J ; Invest New Drugs. 1988 Sep;6(3):147-53.
3 Matthew M. Ames, Dane A. Mathiesen , Joel M. Reid ; Investigational New Drug 1991 Aug;9(3):219-25.
4 G.J. Stevens ,J.L. Burkey ,C.A. McQueen ; Cell Biology and Toxicology February 2000, Volume 16, Issue 1, pp 31–39
5 Simon R, Freidlin B, Rubinstein L, Arbuck SG, Collins J, Christian MC ; Journal of the National Cancer Institute, Volume 89, Issue 15, 6 August 1997, Pages 1138–1147
6 Hong Hou, Hengxue Li, Ying Han and Chaoguo Yan ; Org. Chem. Front., 2018 ,Page 51-54
7 Hong Hou, Hengxue Li, Ying Han and Chaoguo Yan ; Org. Chem. Front., 2018 ,Page 51-54
8 Hong Hou, Hengxue Li, Ying Han and Chaoguo Yan ; Org. Chem. Front., 2018 ,Page 51-54
9 Ramandeep Kaur ,Sundeep Kaur Manjal ,Ravindra K.Rawal ,Kapil Kumar; Bioorganic & Medicinal Chemistry ;Volume 25, Issue 17, 1 September 2017, Pages 4533-4552
10 Atul Kumar ,Vishwa Deepak Tripathi ,Promod Kumar ; Green Chem., 2011, 13, 51-54
11 Taterao M. Potewar ,Sachin A. Ingale ,Kumar V. Srinivasan ; Arkivoc ; Volume 2008, Issue 14, pp. 100-108

無法下載圖示 本全文未授權公開
QR CODE